This study compared the effect of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphisms on the incidence and outcome of sepsis in ventilated very low birth weight infants.
INTRODUCTION
Sepsis, a major cause of morbidity and mortality, is a persistent and vexing problem in very low birth weight (VLBW) infants. The incidence of one or more episodes of late onset bloodstream infection in this population ranges from 25 to 30% with higher rates for infants with birth weights less than 1000 g. [1] [2] [3] [4] Outcome from sepsis depends on the host response. While an absent or diminished host response leads to overwhelming infection, an excessive response can lead to systemic inflammation and multiple organ failure. 5 The renin-angiotensin system (RAS) plays a complex role in the pathophysiology of sepsis. In tissues, angiotensin-converting enzyme (ACE) is expressed by activated macrophages and T lymphocytes. 6 These tissue-derived sources of ACE have been shown to upregulate the inflammatory response. [7] [8] [9] Additionally, T and B lymphocytes, macrophages and neutrophils express angiotensin type 1 receptors. 7, 10, 11 Consistent with a role for ACE in inflammatory processes, ACE inhibitors suppress cytokine production in stimulated mononuclear cells. 8 However, during sepsis there is also a decrease in circulating ACE activity, which correlates with systemic blood pressure. 12, 13 These decreases in serum ACE activity during sepsis may reflect endothelial cell damage or inhibition of ACE activity by bacterial mediators such as lipopolysaccharide (LPS). 14 Because of the important role ACE plays in inflammatory responses, interindividual genetic variation in ACE activity may alter outcome in severe infections. The human ACE gene is located on chromosome 17 (17q23) and contains a polymorphism consisting of either the presence (insertion, I) or absence (deletion, D) of a 287 bp alu repeat in intron 16. 15 The D is associated with increased ACE activity in both tissue and in the circulation and accounts for about 47% of the intraindividual variation in plasma ACE activity. 15, 16 The ACE I/D polymorphism may alter risk for and outcome from sepsis. 17, 18 Since tissue ACE regulates inflammatory responses, the DD genotype or D allele (associated with higher tissue ACE levels) might be associated with adverse outcome from sepsis in VLBW infants.
We determined the influence of the ACE I/D polymorphism on the incidence and outcome of infectious complications in a retrospective case control study of mechanically ventilated VLBW infants.
METHODS
Genomic DNA used for this case controlled study was extracted from archival tracheal aspirate (TA) pellets (260) or blood (35 patients) collected prospectively as part of an ongoing study of genetic factors in the development of complications of prematurity. The TAs that were used as a source of genomic DNA were originally collected as part of long-term longitudinal studies examining cytokine concentrations and the development of CLD. 19, 20 Infants were included in the study if they fulfilled the following inclusion criteria: birth weight less than 1500 g, mechanical ventilation (MV) during the first week of life, complete clinical data on infectious outcome and genomic DNA sample that could be used for genotyping. Infants were excluded if complete data on outcome were not available or suitable DNA was not available. The study was approved by the Institutional Review Board for Human Research at Louisiana State University Health Sciences Center in Shreveport.
Clinical and outcome data were abstracted from the clinical record and included information on respiratory outcome, survival and development of complications of prematurity. The results of all cultures of blood, TA and cerebrospinal fluid were recorded from the patients' charts. Infants were evaluated for sepsis at the discretion of the clinical staff when signs and symptoms compatible with sepsis developed. For the purposes of this study any positive blood culture was considered a blood stream infection (BSI) (bacteremia or fungemia). BSIs were divided into early when the culture was obtained during the first 3 days of life, and late (nosocomial) if it was obtained thereafter. Nosocomial pneumonia was diagnosed when there was radiologic evidence of a new pulmonary infiltrate and the blood and endotracheal aspirate culture grew the same organism. Isolation of an organism from a TA culture in an infant more than 3 days of age without a positive blood culture or a change in chest radiograph was considered colonization. Sepsis mortality was defined as mortality during an acute episode of sepsis.
Laboratory Methods DNA isolation Isolation of total DNA from blood or TA pellets was performed using the QIAmp DNA Mini kitst (Qiagen Incorporated, Chatsworth, CA). Briefly, TA pellets were suspended in 200 ml of sterile phosphate-buffered saline by vigorous vortexing, then digested in proteinase K and applied to silica gel spin columns. Columns were washed in the manufacturer's supplied buffers and the total DNA was eluted in 200 ml elution buffer. Blood (200 ml) was extracted similarly to the TA pellets.
ACE I/D genotyping ACE I/D polymorphism was performed by microplate PCR method as described previously. 21 Primers used in the assay: 5 0 -CTG GAG ACC ACT CCC ATC CTT TCT-3 0 and 5 0 -GAT GTG GCC ATC ACA TTC GTC AGA T-3 0 . In 10 ml PCR volume, the following components were added with the final concentration of MgCl 2 1.5 mM, KCl 50 mM, 5% DMSO, Triton X-100 0.1%, 200 mm each of dNTPs, 10 pmol each primer, 1 to 2 U of Taq polymerase, and 1 ml of DNA. DNA was denatured at 951C for 5 to 10 minutes, followed by 30 cycles of denaturation at 941 for 60 seconds, annealing at 67 for 60 seconds, and extension at 721 for 2 minutes, with a final extension at 721 for 7 minutes. PCR products were separated on 2% agarose gel containing 0.5 mg/ml ethidium bromide. After gel electrophoresis, the bands were visualized by UV transillumination. The PCR product is a 190 bp fragment in the absence of the I (D genotype) and a 490 bp fragment in the presence of the I (I genotype). Genotype calling was performed by one of the authors (KY) who was unaware of the clinical outcomes.
Data analysis Data analysis consisted of comparing the incidence of infection and their complications between the various ACE I/D genotypes. All statistical analysis was performed using the SPSS for Windows version 6.0 (SPSS Inc., Chicago, IL). Differences in frequencies of complications were assessed by w 2 . ANOVA or the Student's t-test was used to assess normally distributed variables where appropriate. The Wilcox Rank Sum test was used for analysis of factors that were not normally distributed. A probability value of less than 0.05 was considered statistically significant. The data are presented as mean±standard error of the mean (SEM).
RESULTS
A total of 295 patients had complete culture and clinical information. Of these, 234 (79%) were African American, 58 (20%) were Caucasian and three (1%) were Hispanic. Mean gestational age and mean birth weight of the study population were 26.7±0.2 weeks and 911±13 g, respectively. Male:female ratio was 180:115. All patients required MV at birth and 265 (90%) infants were treated with exogenous surfactant therapy (Survanta s , Ross Products Division, Abbott Laboratories, Columbus, OH). In all, 159 (54%) infants were oxygen dependent at 28 days and 64 (22%) were oxygen dependent at 36 weeks PCA. There were 41 (14%) patients who died during their initial hospitalization (25 before 28 days of age and 16 after 28 days).
Three patients (1%) had positive blood cultures (two infants with Group B streptococci, one infant Escherichia coli) during the first 3 days of life (early bacteremia) and 146 (49%) had one or more episodes of late (nosocomial) bacteremia or fungemia. Coagulase negative staphylococci (CONS) were the most commonly isolated organisms from blood cultures. A total of 68 (23%) infants had one or more episodes of bacteremia/fungemia other than from CONS and 40 (13.5%) had multiple episodes of bacteremia or fungemia. Organisms causing nosocomial BSI (bacteremia/ fungemia) for the study population are shown in Table 1 . There were 15 (5%) deaths directly attributable to sepsis (overall mortality was 14/295, 13%). Of 15 sepsis related deaths, 14 were associated with a non-CONS BSI (p<0.001, RR ¼ 59.0 95% CI 7.6 to 462). Nosocomial pneumonia was diagnosed in 12 (7%) infants ( Table 1) .
The frequency of the D allele in the study population was 0.60. The frequency of the D allele was similar between AfricanAmerican (0.60) and Caucasian infants (0.59) (p ¼ 0.664). In all, 54 (18.3%) infants were homozygous II, 128 (43.4%) were heterozygous ID and 113 (38.3%) were homozygous DD.
Baseline clinical characteristics of birth weight, gestational age, gender and need for surfactant replacement were not different between genotype groups ( Table 2) .
The ACE I/D polymorphism had no discernable influence on the incidence of BSI, either early or late, in ventilated VLBW infants.
Two (2%) of 128 infants who developed early BSI in the ID group compared to 1/113 (2%) in the DD group and none of the infants with the II genotype (p ¼ 0.621). One or more episodes of late BSI developed in 28 (52%) of 54 infants with the II genotype, 66 (52%) of 128 infants with the ID genotype and 52 (46%) of 113 infants with the DD genotype (p ¼ 0.618). There were no significant differences in organism-specific bacteremia rates between genotype groups (Table 3 ). Neither the rates of non-CONS BSI (II: 24%, ID: 23%, DD: 22%; p ¼ 0.937) nor multiple bacteremic/fungemic episodes (II: 13%, ID: 16%, DD: 12; p ¼ 0.641) were different between genotype groups.
Late onset BSI was the major cause of late mortality in ventilated VLBW infants with 15/16 deaths occurring after 28 days of age directly attributable to BSI (RR 17.0, 95% CI 2.2 to 130.6; p<0.001). Nine of these infants had multiple BSI episodes. The ACE I/D polymorphism had no effect on sepsis-related mortality. Sepsis mortality was (II: 7%, ID: 5%, DD: 4%; p ¼ 0.692). The rate of sepsis mortality for infants with late BSI was (II: 14%, ID: 9%, DD: 10%; p ¼ 0.764).
There was a nonsignificant trend for the development of nosocomial pneumonia infants with the ACE D allele (II: 2%, ID: 6%, DD: 11%; p ¼ 0.096). The incidences of infection in other sites were not different between genotype groups. CSF infections (mainly (9) 42 (14) 28 ( related to ventriculoperitoneal shunt placement) occurred in one (2%) infant with the II genotype, one (2%) infant with the ID genotype and in five (4%) infants who were DD (p ¼ 0.707).
DISCUSSION
Genetic differences in the inflammatory response may play a role in determining outcome from serious infections. The ACE I/D polymorphism by virtue of is effects on tissue ACE activity and subsequent downstream upregulation of inflammation make it a potential candidate gene to modify outcome in infection. The role of the ACE polymorphism has received extensive study in several disease states but relatively little is known of its role in determining the outcome of infections. 17, 18, 22 The frequency of the D allele (0.60) in our study population of mechanically ventilated VLBW infants is not different than previously reported in our local population or for other groups. 16, 21, 23 This finding suggests that the D allele is not a risk or protective factor for either premature birth or the need for mechanical ventilation.
The ACE I/D polymorphism was not a significant risk factor for the development of infectious complications in this group of mechanically ventilated VLBW infants. The incidence of both early (presumably vertically acquired at birth) and late BSI was not influenced by the ACE I/D polymorphism. Additionally, the types of organisms causing late BSI were not affected by the ACE polymorphism. It is therefore likely that other factors such as immaturity, the need for central venous access or other genetic risk factors play a greater role in determining the risk for BSI in premature infants than the ACE gene.
The ACE polymorphism did not affect mortality once BSI developed. Unlike the association of ACE DD genotype with increased mortality in older children with meningococcemia, the ACE polymorphism did not affect mortality once BSI developed in mechanically ventilated VLBW infants. 18 This may be due, in part, to the relatively low numbers of BSI with more pathogenic types of bacteria or fungi. The majority of late BSI infections were CONS which is not associated with high mortality rates. 4 Morimoto et al. 17 found that the D allele is a risk factor for pneumonia in the elderly. We found a nonsignificant trend for increased nosocomial pneumonia in patients with the D allele in our study group. Whether this trend would persist if a larger number of patients were available to analyze is unknown.
It is very likely that other genetic differences play a role in determining risk of poor outcome in sepsis. Polymorphisms in cytokines, their receptors and bacterial pattern recognition molecules have been suggested to alter the course of sepsis. We recently reported in a subset of this population that the TNF-a À308 G/A SNP affects sepsis related mortality. 24 Others have reported that the IL-6 À174 G/C SNP and the 3020insC mutation of the NOD2 gene are associated with increased risk of sepsis in VLBW infants. 25, 26 The observations of this retrospective case controlled study are limited by selection bias. Our population of mechanically ventilated infants, most of whom were less than 1000 g at birth, is at high risk for infection. As a result, the incidence of bacteremia/fungemia in our population studied (47%) is higher than generally reported for a VLBW population and also higher than for the population of VLBW infants in our NICU (approximately 30%).
2 MV and lower birth weight are known risk factors for late onset sepsis. 27 Because only infants who were mechanically ventilated were included, the true impact of this polymorphism on the incidence of infectious complications of prematurity may be underestimated. 
